CAP XX Ltd (CPX)
CPX Share PerformanceMore
|52 week high||12.9400 30/01/17|
|52 week low||3.1500 04/04/16|
|52 week change||2.7000 (49.54%)|
|4 week volume||41,378,759 25/02/17|
Latest News« previous» nextMore
20/03/2017 - 16:54 StockMarketWire
Weak pharma, banking and oil stocks left the FTSE flat on Monday, while the pound rose 0.5% against the euro after Prim...
20/03/2017 - 08:49 StockMarketWire
London equities opened Monday slowly and on a mixed note prior to a raft of UK inflation and EU purchasing-managers...
20/03/2017 - 07:31 StockMarketWire
First half pre-tax losses at CAP-XX rose to A$1.9m - up from A$1.3m last time. Total revenue for the six months to the end o...
20/03/2017 - 07:00 RNS
RNS Number: 8604Z CAP-XX Limited 20 March 2017 Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR). 20 March 2017 CAP-XX Limited ("CAP-XX" or the "Company") Interim Results for the half-year ended 31 December 2016 Further strong growth in licensing and new product...
09/03/2017 - 07:50 StockMarketWire
CAP-XX has launched two new ranges of supercapacitors for applications in the Internet of Things (IOT).
09/03/2017 - 07:00 RNS
RNS Number: 9340Y CAP-XX Limited 09 March 2017 Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR). 9 March 2017 CAP-XX Limited ("CAP-XX" or "the Company") CAP-XX launches new ranges of cylindrical supercapacitors CAP-XX is pleased to announce that it has launched...
01/02/2017 - 07:00 RNS
RNS Number: 6359V CAP-XX Limited 01 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii CAP-XX LTD 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or...
24/01/2017 - 07:00 RNS
RNS Number: 9301U CAP-XX Limited 24 January 2017 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 ("MAR"). IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN THIS ANNOUN...
Equity Research (CPX)
Ergomed (ERGO.L) 182.5p £73.9m The Company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, has announced the initiation of a phase...
Latest discussion posts More
“hard drop this morning - as perhaps expected - picked up some shares for the rebound and can see there is some strong buying volume. spread tight which is encouraging though ...”▼
“Whilst this seems to be lining up a lot of potential and opportunities there are plenty of caveats in the news. Feels a little cautious still, with significant revenue drop not ...”▼
“Chart update note: http://bonker99.com/charts”▼
Codes & Symbols
|Symbols||CPX, LSE:CPX, CPX.L, CPX:LN, LON:CPX, XLON:CPX|